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DBackground: The development of acute kidney injury (AKI) after coronary artery bypass graft (CABG) surgery
is associated with increased short- and long-term mortality. Whether AKI has a causal relationship with subse-
quent mortality or whether the development of AKI simply occurs in patients with more comorbidity undergoing
more complex procedures remains unresolved.
Methods and Results: This was an observational cohort study of prospectively collected data from 4694
patients discharged from the hospital after first-time CABG surgery at a tertiary cardiac center between 2003
and 2008. AKI was defined using the Risk, Injury, Failure, Loss, and End stage (RIFLE) criteria, which require
at least a 50% increase in serum creatinine. The primary outcome measure was all-cause mortality determined
via UK Office of National Statistics. A total of 562 (12.0%) of patients developed AKI after CABG surgery.
Patients who developed AKI were older, more likely to be female, and had more comorbidity than patients
who did not develop AKI. In a Coxmultivariable analysis, the development of AKI was an independent predictor
of midterm mortality (hazard ratio, 1.80; 95% confidence interval, 1.50-2.16). Subsequently, a comparison of
562 patients who sustained AKI with 562 propensity score–matched patients who did not sustain AKI was un-
dertaken. After propensity matching, baseline clinical and operative characteristics were similar between both
groups. After Cox multivariable analysis of the propensity-matched cohort, AKI remained an independent pre-
dictor of midterm mortality (hazard ratio, 1.52; 95% confidence interval, 1.19-1.93).
Conclusions: The development of AKI after CABG is a serious event associated with worse midterm survival.
This excess mortality cannot be explained simply by coexisting comorbidity and surgical complexity. (J Thorac
Cardiovasc Surg 2014;147:989-95)A
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Acute kidney injury (AKI) is a common problem after car-
diac surgery. Depending on definition, AKI may complicate
more than 30% of cardiac operations,1,2 with 1% to 2% of
patients subsequently requiring postoperative dialysis.3-5 It
is likely that the etiology of AKI after cardiac surgery is
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The Journal of Thoracic and Cadisease, left ventricular impairment, and procedural
complexity with prolonged cardiopulmonary bypass and
aortic cross times being important predictors of its
subsequent development.3,6,7
The need for dialysis after cardiac surgery is a serious event
associated with a marked increase in early morbidity and mor-
tality.3 Recently, evidence has emerged to suggest that AKI, de-
fined by smaller postoperative increases in serum creatinine
(sCr), is also associated with a poor prognosis after cardiac sur-
gery.2,8,9 This evidence is primarily derived form retrospective
analyses of large cardiac surgical data sets or observational
studies and may be confounded by the fact that patients with
the highest burden of comorbidity before surgery or those
undergoing the most complex operations are most likely to
develop postoperative AKI. By virtue of comorbid disease or
procedural complexity, these patients are likely to have
a worse postsurgical prognosis independent of the
development of AKI. Whether AKI has a causal relationship
with subsequent mortality or whether the development of AKI
simply reflects comorbidity and/or procedural complexity
within a high-risk patient population remains unresolved.
Wehave undertaken an observational single-center cohort
study at a tertiary cardiothoracic surgical unit in London,rdiovascular Surgery c Volume 147, Number 3 989
Abbreviations and Acronyms
AKI ¼ acute kidney failure
CI ¼ confidence interval
CKD ¼ chronic kidney disease
eGFR ¼ estimated glomerular function rate
HR ¼ hazard ratio
LV ¼ left ventricular
RIFLE ¼ Risk, Injury, Failure, Loss, and End stage
sCr ¼ serum creatinine
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DUnited Kingdom, to evaluate the impact of AKI on survival
of patients after coronary artery bypass graft (CABG)
surgery. By using propensity score matching, we have min-
imized the impact of patient comorbidity and surgical com-
plexity on midterm mortality after cardiac surgery.METHODS
Patients and Setting
This study analyzes consecutive patients undergoing isolated first-time
CABG surgery at Barts Health National Health Service Trust, who survived
to hospital discharge. During the study period of January 1, 2003, to Decem-
ber 31, 2007, 4891 patients underwent first-timeCABG surgery, of whomwe
excluded 87with incomplete surgical database records, 35 established on pre-
operative renal replacement therapy, and 75 who died in the hospital postop-
eratively. The final study cohort comprised 4694 patients (96.0% of all first-
timeCABGoperations during the studyperiod)who, for subsequent analysis,
were divided into 2 groups: those who developed AKI (AKI group, n¼ 562)
and those who did not develop AKI (no AKI group, n ¼ 4132) (Figure 1).
We prospectively excluded patients who died in the hospital postopera-
tively from subsequent analysis. This was to not confound analysis of the
effect of AKI on longer-term mortality.
Definition of AKI
AKI was defined according to the Risk, Injury, Failure, Loss, and End
stage (RIFLE) classification by the change in sCr postoperatively compared
with baseline sCr. This classification system requires sCr levels to increase
by at least 50% from baseline to be classified as AKI.10 Baseline sCr levels
were obtained 2 days before CABG surgery. Postoperatively, sCr was mea-
sured daily for the first postoperativeweek unless the patientwas discharged
within this period. Patients sustaining AKI were further stratified according
to RIFLE class: RIFLE-R corresponds to a 50% increase in sCr, RIFLE-I to
a 100% increase in sCr, and RIFLE-F to a 200% increase in sCr.
Data Collection
Detailed clinical information was recorded at CABG surgery. This infor-
mation included age, sex, body mass index, symptom status (New York
Heart Association class andCanadian Cardiovascular Society angina status),
previous cardiac history (prior myocardial infarction, time since myocardial
infarction and prior percutaneous coronary intervention, and preoperative
atrial fibrillation), prior medical history (diabetes mellitus, hypertension, pe-
ripheral vascular disease, previous stroke or transient ischemic attack, and
chronic obstructive pulmonary disease), and baseline renal function (sCr
and estimated glomerular function rate [eGFR]). The GFR was estimated
from theModification of Diet in Renal Disease equation.11 Procedural infor-
mation recorded included the anatomical severity of coronary artery disease,
preoperative left ventricular function, and operative data (including use of
cardiopulmonary bypass, cross-clamp time, perfusion time, use of internal
thoracic arterial grafts, use of preoperative intra-aortic balloon pump, and990 The Journal of Thoracic and Cardiovascular Surgprocedural urgency). Procedural urgency was defined as urgent or elective.
Urgent indicated that either medical factors or anatomical severity of coro-
nary artery disease required the patient to stay in the hospital for his or her
surgery after coronary angiography. Elective surgery was defined as patients
fit to be discharged from the hospital after coronary angiography, with read-
mission for surgery at a later date.
Outcome Measures
The primary study end point was all-cause mortality. The UK Office of
National Statistics periodically links live/death status of treated patients to
our unit’s surgical database as part of the National Central Cardiac Audit
Database. Study patients were followed up until August 2011 (median
follow-up, 5.6 years; interquartile range, 4.2-6.9 years). In addition, early
in-hospital outcomes, including perioperative stroke, need for resternot-
omy, and length of hospital stay, were recorded.
Statistical Analysis and Propensity Score Matching
All statistical analyses were performed using SPSS, version 18.0 (SPSS,
Inc, Chicago, Ill). Baseline patient, procedural, and postoperative charac-
teristics were compared between the 2 groups. Categorical data are summa-
rized using absolute values (percentage). Normally distributed, continuous
data are presented as mean  SD or, where skewed, as median (interquar-
tile range). Normally distributed continuous variables were compared us-
ing Student t tests, and the Mann-Whitney U test was used to compare
nonnormally distributed continuous variables. Categorical data were com-
pared using the Pearson c2 test.
Baseline comorbidity was unbalanced between the AKI and no AKI
groups. A nonparsimonious logistic regression model with AKI as the de-
pendent variable (c-statistic, 0.775) was constructed to adjust for the con-
founding of baseline comorbidity and surgical complexity. Covariates in
the model included age, sex, body mass index, previous myocardial infarc-
tion, hypertension, previous stroke, peripheral vascular disease, 3-vessel
coronary disease, left main stem disease, left ventricular (LV) ejection frac-
tion less than 35%, diabetes mellitus, chronic obstructive airway disease,
intra-aortic balloon pump use, internal thoracic artery use, new stroke,
baseline sCr, preoperative atrial fibrillation, procedural urgency, and
need for resternotomy. To balance comorbidity between the study groups,
a greedy matching SPSS macro was used to match the 562 patients who
sustained AKI with 562 patients from the ‘‘no AKI’’ group with similar co-
morbidity. This created a ‘‘propensity-matched no AKI’’ population.
Midterm survival was described using the Kaplan-Meier method, and
comparisons were made using the log-rank statistic. Estimations of risk
were calculated using Cox regression analysis. Potential independent pre-
dictors of outcome were identified by univariate Cox regression analyses,
and all significant univariate predictors (P  .05) were then entered into
the multivariate Cox regression model.
Ethics
The data were collected as part of a mandatory national cardiac audit,
and all patient-identifiable fields were removed before analysis. The local
ethics committee advised that formal ethical approval was not required.
RESULTS
A total of 4694 patients underwent first-time CABG sur-
gery and survived to hospital discharge during the study pe-
riod. A total of 562 patients (12.0%) developed an episode of
postoperativeAKI: of these patients, 342 (7.3%) hadRIFLE-
R, 145 (3.1%) had RIFLE-I, and 75 (1.6%) had RIFLE-F.
Patient and Operative Characteristics (Table 1)
Full unmatched study population. Patients who devel-
oped AKI were older (69.4 vs 66.3 years; P<.0001), moreery c March 2014
4891 patients underwent 
first time isolated CABG 
surgery in study period
197 patients excluded: 
87 patients with incomplete surgical data records 
35 patients undergoing pre-operative RRT 
75 patients that died in hospital
Final study cohort 
4694 patients 
AKI Group 562 
patients
No AKI Group 
4132 patients
FIGURE 1. Flow diagram of patients undergoing first-time isolated coro-
nary artery bypass grafting (CABG) between January 2003 and December
2007, describing patient exclusions and incidence of acute kidney injury
(AKI). RRT, Renal replacement therapy.
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Dlikely to be female (23.7% vs 20.0%; P ¼ .041), and more
likely to have associated comorbidity than patients who did
not develop AKI. Notably, patients who developed AKI
had more severe preoperative angina symptoms (Canadian
Cardiovascular Society class 3-4) (41.5% vs 34.9%;
P ¼ .002) and preoperative heart failure symptoms (New
York Heart Association class III-IV) (30.1% vs 18.8%;
P<.0001). Moreover, diabetes mellitus (46.8% vs 28.8%;
P<.0001), hypertension (86.8% vs 77.0%; P<.0001), pe-
ripheral vascular disease (20.1% vs 11.8%; P<.0001), pre-
vious myocardial infarction (53.9% vs 44.3%; P<.0001),
LV dysfunction (LV ejection fraction,<50%) (48.9% vs
36.0%; P<.0001), preoperative atrial fibrillation (4.6% vs
2.4%; P ¼ .003), chronic obstructive pulmonary disease
(11.9% vs 7.9%; P ¼ .001), and previous stroke (9.9% vs
6.5%; P ¼ .006) were significantly more common in the
AKI group than the no AKI group.
Patients in the AKI group were also more likely to have
undergone urgent CABG surgery (43.8% vs 31.0%;
P<.0001), to have had a preoperative intra-aortic balloon
pump (2.8% vs 1.0%; P<.0001), and less likely to have re-
ceived an internal thoracic arterial graft at surgery (89.1%
vs 91.9%; P ¼ .026) than patients in the no AKI group.
Propensity-matched population. After propensity match-
ing, all baseline patient characteristics were balanced between
the 2 groups, except the presence of left main stem disease,
which was more common in the propensity-matched no AKI
group (30.6%vs24.7%;P¼ .028). Procedural characteristics
were also balanced between the 2 groups after matching.
Renal Characteristics (Table 1)
Full unmatched study population. Themean baseline sCr
and eGFR for all patients were 1.12  0.34 mg/dL and
75.0  26.4 mL/min, respectively. Patients who developed
AKI had significantly higher baseline sCr (1.24 vs
1.10 mg/dL; P<.0001) and lower baseline eGFR (68.9 vs
75.9 mL/min; P<.0001) than patients who did not develop
AKI. Patients with preoperative chronic kidney diseaseThe Journal of Thoracic and Ca(CKD) 3 (eGFR, 30-60 mL/min) (40.6% vs 27.5%) and
CKD 4 (eGFR,<30 mL/min) (4.3% vs 0.9%) were more
common in the AKI group than the no AKI group
(P<.0001). Peak postoperative sCr was higher in the AKI
group (2.58 vs 1.22 mg/dL; P<.0001). Only 21 (3.7%) of
the patients with AKI required postoperative dialysis.
Propensity-matched population. Baseline sCr and eGFR
were not different, and there was no difference in the pro-
portion of patients with CKD 3 (40.6% vs 38.8%) or
CKD 4 (4.3% vs 2.5%) between the AKI and no AKI
groups after propensity matching. Obviously, peak postop-
erative sCr remained different between the groups.
Early Postoperative Outcomes in Full Unmatched
Population (Table 1)
Full unmatched study population. Postoperative stroke
(1.4% vs 0.3%; P< .0001) and need for resternotomy
(5.5% vs 1.8%; P< .0001) were significantly higher in
the patients who developed AKI. Furthermore, length of
hospital stay was longer for patients who developed AKI
when compared with patients who did not develop AKI
(14 vs 7 days; P<.0001).
Propensity-matched population. After propensity match-
ing, there was no difference in postoperative stroke or need
for resternotomy between the groups. Length of hospital
stay remained longer for patients who developed AKI com-
pared with patients who did not (14 vs 8 days; P<.0001).
Midterm All-Cause Mortality After CABG
Full unmatched study population. Patients who sus-
tained AKI had higher mortality rates during follow-up
(1 year, 8.6% [95% confidence interval {CI}, 3.8%-
15.7%]; and 5 year, 24.2% [95% CI, 18.4%-30.4%])
than patients who did not sustain AKI (1 year, 2.4%
[95% CI, 1.2%-4.7%]; and 5 year, 10.6% [95% CI,
8.5%-13.1%]) (log rank P<.0001) (Figure 2, A).
Mortality rates among patients with RIFLE-R were 6.7%
(95% CI, 1.7%-16.7%) at 1 year and 22.6% (95% CI,
15.5%-30.64%) at 5 years. In patients with RIFLE-I, the
1-year mortality rate was 11.8% (95% CI, 3.2%-26.5%)
and the 5-year mortality rate was 28.0% (95% CI,
17.2%-38.8%), and in patients with RIFLE-F, the 1-year
mortality rate was 10.7% (95% CI, 1.2%-32.7%) and the
5-year mortality rate was 21.9% (95% CI, 8.3%-39.5%).
Propensity-matched population. After propensity match-
ing, midterm mortality remained higher in the AKI group
than the propensity-matched noAKIgroup (1-yearmortality.
5.0% [95% CI, 1.3%-12.6%]; and 5-year mortality, 17.3%
[95%CI, 11.6%-24.0%]) (log rankP¼ .0008) (Figure 2,B).
Predictors of Midterm All-Cause Mortality After
CABG
Full unmatched study population. The development of
AKI (hazard ratio [HR], 1.80; 95% CI, 1.50-2.16), agerdiovascular Surgery c Volume 147, Number 3 991
TABLE 1. Clinical and procedural characteristics of the unmatched and matched study cohorts according to the development of AKI
No AKI (n ¼ 4132) AKI (n ¼ 562) P value
Propensity-matched
no AKI (n ¼ 562) P value
Patient characteristics
Age, y 66.3  9.6 69.4  9.2 <.0001 69.3  8.9 .937
Female sex 825 (20.0) 133 (23.7) .041 149 (26.5) .271
BMI 27.72  5.31 28.50  5.85 .001 28.62  6.20 .740
CCS 3-4 1142 (34.9) 233 (41.5) .002 250 (44.5) .306
NYHA III-IV 778 (18.8) 169 (30.1) <.0001 150 (26.7) .209
Hypertension 3182 (77.0) 48 (86.8) <.0001 492 (87.5) .721
Diabetes mellitus 1188 (28.8) 263 (46.8) <.0001 281 (50.0) .281
Previous MI 1830 (44.3) 303 (53.9) <.0001 293 (52.1) .550
MI within 30 d 467 (11.3) 115 (20.5) <.0001 117 (20.8) .677
Previous PCI 419 (10.1) 45 (8.0) .102 61 (10.9) .112
COPD 326 (7.9) 67 (11.9) .001 67 (11.9) 1.00
Preoperative atrial fibrillation 101 (2.4) 26 (4.6) .003 28 (5.0) .780
Previous stroke 267 (6.5) 54 (9.6) .006 58 (10.3) .690
Peripheral vascular disease 489 (11.8) 113 (20.1) <.0001 111 (19.8) .881
LV ejection fraction,% <.0001 .411
35-50 1225 (29.6) 213 (37.9) 198 (35.2)
<35 264 (6.4) 62 (11.0) 55 (9.8)
3-Vessel coronary disease 2781 (67.3) 415 (73.8) .002 417 (74.2) .892
Left main stem disease 1058 (25.6) 139 (24.7) .656 172 (30.6) .028
Procedural characteristics
Procedural urgency 1281 (31.0) 246 (43.8) <.0001 251 (44.7) .764
CPB 3817 (92.4) 526 (93.6) .303 528 (93.6) .805
Perfusion time 81.1  40.2 84.0  39.2 .246 80.3  37.1 .233
Cross-clamp time 55.83  22.5 55.77  22.1 .963 56.55  20.6 .602
ITA use 3798 (91.9) 501 (89.1) .026 489 (87.0) .269
Preoperative IABP 40 (1.0) 16 (2.8) <.0001 15 (2.7) .855
Renal characteristics
Baseline sCr (mg/dL) 1.11  0.31 1.24  0.58 <.0001 1.21  0.58 .388
Baseline eGFR (mL/min/1.73 m2) 75.9  26.0 68.6  28.5 <.0001 68.5  24.7 .931
Baseline CKD class <.0001 .176
CKD 1 and 2 (eGFR>60) 2957 (71.6) 310 (55.1) 330 (58.7)
CKD 3 (eGFR 30-60) 1136 (27.5) 228 (40.6) 218 (38.8)
CKD 4 (eGFR<30) 39 (0.9) 24 (4.3) 14 (2.5)
Peak sCr 1.22  0.41 2.58  1.24 <.0001 1.38  0.76 <.0001
Postoperative dialysis 0 (0) 21 (3.7) <.0001 0 (0) <.0001
Early postoperative outcomes
New stroke 12 (0.3) 8 (1.4) <.0001 4 (0.7) .246
Return to theater 75 (1.8) 31 (5.5) <.0001 29 (5.2) .791
Length of stay 7 (6-11) 14 (8-27) <.0001 8 (6-14) <.0001
AKI, Acute kidney injury; BMI, body mass index; CCS, Canadian Cardiovascular Society; NYHA, New York Heart Association; MI, myocardial infarction; PCI, percutaneous
coronary intervention; COPD, chronic obstructive pulmonary disease; LV, left ventricular; CPB, cardiopulmonary bypass; ITA, internal thoracic artery; IABP, intra-aortic balloon
pump; sCr, serum creatinine; eGFR, estimated glomerular filtration rate; CKD, chronic kidney disease.
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95% CI, 1.12-1.52), baseline eGFR (HR, 0.94; 95% CI,
0.90-0.98), and preoperative comorbidities (diabetes melli-
tus [HR, 1.38; 95% CI, 1.18-1.61], chronic obstructive pul-
monary disease [HR, 1.69; 95% CI, 1.70-2.08], LVejection
fraction<35% [HR, 2.15; 95% CI, 1.74-2.66], 3-vessel
coronary artery disease [HR, 1.23; 95% CI, 1.03-1.45],
and preprocedural atrial fibrillation [HR, 1.52; 95% CI,
1.09-2.12]) were all associated with significantly increased
risk of midterm postoperative all-cause mortality in the un-
matched analysis (Table 2).992 The Journal of Thoracic and Cardiovascular SurgPropensity-matched population. After propensity score
matching, development of AKI remained an independent
predictor associated with increased midterm mortality risk
(HR, 1.52; 95% CI, 1.19-1.93) (Table 2).DISCUSSION
In this large, single-center cohort of patients undergoing
first-time CABG surgery who survived to hospital dis-
charge, the development of AKI was associated with an in-
crease in all-cause mortality during midterm follow-up. Byery c March 2014
FIGURE 2. Long-term survival of patients with and without acute kidney injury (AKI) during hospitalization: unmatched (A) andmatched (B) populations.
LR, Log rank; CABG, coronary artery bypass grafting.
Gallagher et al Acquired Cardiovascular Disease5 years after CABG surgery, an absolute difference in mor-
tality of 13.6%was evident between patients who sustained
AKI and those who did not. Other than poor LV function,
developing AKI was the most powerful independent predic-
tor of death in our cohort.
The aim of this study was to investigate the association
between perioperative AKI, patient comorbidity and/or sur-
gical complexity, and midterm mortality after cardiac sur-
gery. We were interested in establishing if AKI was an
independent predictor of adverse outcome in our cohort.
Consistent with our findings, numerous studies have re-
ported that the development of AKI after cardiac surgeryTABLE 2. Independent predictors of long-term mortality in the
unmatched and matched study cohorts
Hazard
ratio 95% CI P value
Unmatched population: Multivariate analysis
Age (per y) 1.06 1.05-1.07 <.0001
Development of AKI 1.80 1.50-2.16 <.0001
Diabetes mellitus 1.38 1.18-1.61 <.0001
COPD 1.69 1.37-2.08 <.0001
Preoperative atrial fibrillation 1.52 1.09-2.12 .014
LV ejection fraction<35% 2.15 1.74-2.66 <.0001
3-Vessel coronary disease 1.23 1.03-1.45 .020
Preoperative eGFR (per 10-mL/min
increase)
0.94 0.90-0.98 .005
Procedural urgency 1.30 1.12-1.52 .001
Matched population: Multivariate analysis
Age (per y) 1.04 1.02-1.06 <.0001
Preoperative atrial fibrillation 1.63 1.05-2.54 .030
Previous stroke 1.62 1.15-2.28 .006
Procedural urgency 1.33 1.03-1.71 .028
LV ejection fraction<35% 2.23 1.64-3.04 <.0001
Development of AKI 1.52 1.19-1.93 .001
Baseline sCr 0.92 0.87-0.98 .013
AKI, Acute kidney injury; COPD, chronic obstructive pulmonary disease; LV, left
ventricle; eGFR, estimated glomerular filtration rate; sCr, serum creatinine; CI, con-
fidence interval.
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Dis associated with an increase in long-term mortal-
ity.2,4,7,8,12 Patients with the highest burden of
preoperative comorbidity and those undergoing the most
complex cardiac surgical procedures more commonly
develop postsurgical AKI.3,13-15 More important,
presurgical and surgical factors may confer a worse
postsurgical prognosis, independent of the development of
AKI, and, thus, confound previous analyses.
As expected, in our cohort, patients who developed AKI
were older, had more comorbid disease and worse preoper-
ative renal function, and were more likely to have under-
gone urgent surgery. Potentially any or all of these factors
may affect subsequent mortality. However, when the effects
of comorbidity and surgical complexity were controlled in
a multivariable model, the development of AKI still re-
mained a powerful independent predictor of mortality
(HR, 1.80). To further assess the association between AKI
and postoperative mortality, a propensity score matching al-
gorithm was used to match comorbidity and surgical com-
plexity between patients who developed AKI and those
who did not. This matching approach achieved 2 well-
balanced groups for both comorbidities and surgical factors.
After matching for comorbidity, the development of AKI
still remained associated with a significant increase in
5-year mortality (24.2% vs 17.3%). Because no matching
process can eliminate all differences between 2 groups of
subjects, multivariable analysis was used to control for re-
maining differences in baseline comorbidity. After multi-
variable analyses, AKI remained an independent predictor
of midterm mortality risk in the propensity-matched cohort
(HR, 1.52).
To our knowledge, this is the first study to use a propensity
score matching approach to assess the association between
postoperative AKI and midterm mortality. Although pro-
pensity score matching is usually used to account for treat-
ment selection bias in observational studies, it can also be
used to compile patient cohorts, with and without an expo-
sure, who are equivalent in all other baseline factors.rdiovascular Surgery c Volume 147, Number 3 993
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dependent variable, without knowledge of midterm mortal-
ity outcomes, just as investigators remain blinded during
a randomized clinical trial. The propensity score matching
algorithm allowed patient and surgical factors associated
with the development of AKI to be balanced between the
AKI and the matched no-AKI control group. The mortality
in the propensity score–matched no-AKI group was higher
than that seen in the unmatched population no-AKI group.
This confirms the midterm prognostic importance of the co-
morbid conditions associated with the development of AKI
that we incorporated into the propensity score algorithm.
However, despite the use of these statistical techniques,
we acknowledge that a cause-and-effect relationship be-
tween postoperative AKI and midterm mortality cannot
be established with our observational data alone. Of all
the factors that we studied, AKI is a powerful predictor of
mortality after CABG. Only poor preoperative LV function
carried a greater risk of death than developing AKI.
When interpreting our results, the early morbidity rates
for our study cohort appear low. This finding is explained
by our choice to prospectively exclude patients who died
in the hospital postoperatively from our subsequent analy-
sis. A significant proportion of these patients developed
AKI. These patients represented a group with multiorgan
failure (data not shown), rather than a primary renal patho-
logical condition. Inclusion of these patients with multior-
gan failure who died early would have confounded any
subsequent analysis of the effect of AKI on midterm
mortality.
AKI after cardiac surgery most likely results from a mul-
tifactorial renal insult that includes ischemia-reperfusion
injury, the systemic inflammatory response to cardiopulmo-
nary bypass, perioperative hemodynamic instability, micro-
embolism, and/or the perioperative administration of
nephrotoxins (eg, nonsteroidal anti-inflammatory drugs,
angiotensin-converting enzyme inhibitors, or iodinated
contrast media).16 Why AKI is associated with long-term
mortality is incompletely understood. In some patients,
the surgical procedure may result in irreversible renal injury
and the development of CKD, which is itself independently
associated with subsequent mortality.17 Postoperative sCr is
a powerful predictor of long-term mortality after cardiac
surgery.18 However, AKI with complete resolution of renal
function (measured by sCr) is also associated with an
increase in long-term mortality, although several of these
patients may subsequently develop CKD.2,19
Our study confirms AKI as a common problem after car-
diac surgery, and that the development of this complication
may identify patients with an increased risk of subsequent
mortality after hospital discharge. There are no established
prophylaxes or therapies proved to reduce the incidence or
the mortality associated with this condition. We hope this
study will stimulate the closer postdischarge monitoring994 The Journal of Thoracic and Cardiovascular Surgof patients who sustain AKI after cardiac surgery. There
is little specific follow-up of these patients. AKI may result
in ongoing progressive renal damage beyond the acute renal
insult, despite the normalization of sCr. This is an important
message for cardiologists, cardiac surgeons, and renal phy-
sicians responsible for the care of these patients after
cardiac surgery. Although future studies are needed to de-
termine the optimal postdischarge follow-up and
management of patients who sustain perioperative AKI,
we believe that aggressive therapy to optimize control of
cardiovascular risk factors should form the mainstay of
the current management for these high-risk patients.
Study Strengths and Limitations
The main strength of this study is that it objectively as-
sesses outcomes after CABG in a large contemporary cohort
of consecutive patients. This means that our results are rele-
vant to a broad patient population. Prospectively collected
data on short-term morbidity were collected in addition to
the primary end point of all-cause mortality.
There are several limitations to this study. First, our pri-
mary end point is all-cause mortality, rather than cardiac
death, and it is possible that other disease processes could
have affected outcome. Second, as with all observational
cohort studies, it was open to residual bias and unknown
confounding factors. The propensity score–matching algo-
rithm allowed the generation of comparable study groups,
but our c-statistic for the algorithm suggests that there
may be missing covariates that could affect longer-term
mortality after CABG surgery. The purpose of multivariable
analysis of the propensity-matched cohort was to correct for
any residual differences in baseline comorbidity. Third, we
have no data on postoperative urine output. Urine output, in
addition to sCr, forms the basis of the RIFLE classification
system. It is possible that some patients who did not meet
RIFLE sCr criteria would have been reclassified as having
sustained AKI if urine output data were available. Fourth,
the risk of AKI after cardiac surgery is increased when cor-
onary angiography and surgery occur in close succession.
We have no data on timing of coronary angiography in re-
lation to cardiac surgery. Because all elective patients
were discharged from the hospital after coronary angiogra-
phy to wait for admission for cardiac surgery at a later date,
it is likely that early cardiac surgery after coronary angiog-
raphy only occurred in patients undergoing urgent cardiac
surgery. Procedural urgency was incorporated within our
propensity-matching model and, thus, was evenly balanced
between our AKI and propensity-matched no AKI groups.
Finally, patients who sustain AKI after cardiac surgery
may be less likely to receive beneficial cardiovascular risk
modification therapies before hospital discharge (most no-
tably, angiotensin-converting enzyme inhibitors in patients
with LV dysfunction). We have no data on patient medical
therapy at hospital discharge. If these therapies are notery c March 2014
Gallagher et al Acquired Cardiovascular Diseasesubsequently optimized during outpatient follow-up, this
may affect long-term outcome.CONCLUSIONS
In our large, single-center observational study, the devel-
opment of AKI after CABG surgery is independently asso-
ciated with worse midterm survival, both in our unmatched
and propensity score–matched cohorts. Our multivariable
models and propensity score matching approaches suggest
that this excess mortality after hospital discharge cannot
be explained simply by preoperative comorbidity or surgi-
cal complexity.
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